Patients First: Implementing Opioid Assessment - Patient’s Story

Date:
November 7, 2019 - November 6, 2020
Open

Patients First: A Practical Approach to Implementing Opioid Assessment into Practice

Part I -Patient’s Story

Target Audience: 

Only open to Alberta pharmacists registered with the Alberta College of Pharmacy. 

 

This session will benefit any pharmacist regardless of their practice setting.

 

Description: 

In response to the ongoing opioid crisis, ACP developed new Opioid Guidelines to support and direct pharmacists when assessing patients who use opioid medications.  Opioid medications potentially pose a significant hazard to patients and to the public and, in addition to pain management, pharmacists must be prepared to deal with the possibility of addiction, misuse, and drug diversion.  Together, RxA and ACP hosted an opioid focused program aimed at helping pharmacists understand how to engage with a patient during an opioid assessment. This session describes a patient’s story.

 

Presenters:  
Rosalind Davis, Family and Patient Advocate 

 

Rosalind Davis lost her partner, Nathan, to fentanyl overdose in 2016. Feeling that not enough awareness and accurate information was available, she and Nathan’s sister (Jessica Holtsbaum) founded Changing the Face of Addiction (www.changethefaceofaddiction.com )

 

The Alberta Foundation for Changing the Face of Addiction is dedicated to creating awareness of the need to treat substance-use disorders (SUD) and substance use with evidence, support and compassion. 

 

The stigma attached to addiction is often the most difficult barrier to overcome and is commonly rooted in misunderstanding. The organization aims to educate society about substance-use and the way it impacts its victims, their families and communities. The organization believes that if we see the person first then we can change the way addiction looks.

 

Objectives: 

  1. Recognize the importance of putting the patient first, and approaching each patient as an individual to meet their unique healthcare needs
  2. Outline the role of pharmacists in opioid assessments for the improved health and wellbeing of patients

 

Accreditation: 

CCCEP Program #: 8007-2019-2924-I-P

Expires: November 6, 2020

CEU’s:  0.25

Attendees will receive a Statement of Attendance following the successful completion of the post-exam.  A score of 70% or greater is required on the post-exam.

 

Registration:   

Registration for this course will grant you access to the presentation and materials for a period of 90 days.  Please ensure you complete the course within 90 days of registering.

 

Fees:

RxA Member Fee:             $0.00 (no charge)

Non-member Fee:            $25.00

 

The value of this course is $25.00

  

Please contact the Alberta Pharmacists' Association at rxa@rxa.ca if you have questions about this session.

 

Cancellation and Refunds: 
Not applicable. 

 

Difficulty Registering Online? 

Download our registration form, fill it out, and fax it back to us at 780-990-1236.

We'll process it the next business day and you'll receive a confirmation by e-mail. 

 

Only open to Alberta pharmacists registered with the Alberta College of  Pharmacy  

Member Fee:  $0.00
Student Fee:  $0.00
Non-Member Fee:  $25.00